GLP-1 Boom Sparks Potential 'Bubble Effect,' Shrinking Competition In Big Pharma, Warns Deloitte: 'The Question Is...'

Clinical OMICsNatural Compounds in Cranberry Juice May Enhance Antibiotic Treatment of UTIs

Clinical OMICsBreast Cancer Prevention Drug Endoxifen Shows Promise at Low Doses

FierceBiotechPassage launches strategic review and 75% layoffs after gene therapy path blocked by FDA

IlluminaFinal Trades: Uber, Exxon, Illumina and Diamondback Energy - CNBC

Endpoints NewsFDA search for new CBER head focused on small group of final candidates

FierceBiotech‘A concerted industry-government effort’: Strand Therapeutics CEO Jake Becraft on FDA’s IND reform and China

BioPharma DiveCelcuity strengthens case for ASCO-spotlighted breast cancer drug

Endpoints NewsSupreme Court restores mifepristone access by mail

Clinical OMICsBiomarker of Epigenetic Aging Could Signal Depression

AmgenPfizer vs. Amgen: Which Big Pharma Stock Is the Better Value Right Now? - TIKR.com

FierceBiotechMirum maps FDA path after anti-itch candidate scores ph. 2 win

Samsung BiologicsCDMO Samsung Biologics estimates $102M impact stemming from ongoing union strike - Fierce Pharma